Hypoxia signalling controls metabolic demand.

It has been known for quite some time that cancer cells undergo far-reaching modifications in their metabolism, yet a full understanding of these changes and how they come about remains elusive. Even under conditions of plentiful oxygen, cancer cells choose to switch glucose metabolism from respiration to lactic acid formation. The mystery behind the molecular mechanisms of this phenomenon, known as the Warburg effect, is now being unravelled. The reduced respiration rate and increased glucose uptake associated with lactic acid production, and acidosis of the micro-environment, are primarily due to activation of the alpha/beta hypoxia-inducible transcription factor. This distinctive metabolic nature of cancer cells is already being exploited as a diagnostic tool but is yet to be harnessed as a therapeutic intervention.

[1]  J. Pouysségur,et al.  ARDent about acetylation and deacetylation in hypoxia signalling. , 2006, Trends in cell biology.

[2]  J. P. McCoy,et al.  The Mammalian Target of Rapamycin (mTOR) Pathway Regulates Mitochondrial Oxygen Consumption and Oxidative Capacity* , 2006, Journal of Biological Chemistry.

[3]  Oksana Gavrilova,et al.  p53 Regulates Mitochondrial Respiration , 2006, Science.

[4]  E. Oldfield,et al.  Expression of hypoxia-inducible carbonic anhydrases in brain tumors. , 2005, Neuro-oncology.

[5]  C. Supuran,et al.  Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pH , 2004, FEBS letters.

[6]  L. Gerweck,et al.  Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics , 2006, Molecular Cancer Therapeutics.

[7]  Eyal Gottlieb,et al.  TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis , 2006, Cell.

[8]  M. Gruber,et al.  Hypoxia-inducible factors, hypoxia, and tumor angiogenesis , 2006, Current opinion in hematology.

[9]  J. Pouysségur,et al.  The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. , 2006, Cancer research.

[10]  Eyal Gottlieb,et al.  Mitochondrial tumour suppressors: a genetic and biochemical update , 2005, Nature Reviews Cancer.

[11]  G. Semenza,et al.  HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. , 2006, American journal of physiology. Lung cellular and molecular physiology.

[12]  G. Semenza,et al.  HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. , 2006, Cell metabolism.

[13]  J. Pastorek,et al.  The role of carbonic anhydrase IX overexpression in kidney cancer. , 2005, European journal of cancer.

[14]  Chi V Dang,et al.  Multifaceted roles of glycolytic enzymes. , 2005, Trends in biochemical sciences.

[15]  W. Kaelin,et al.  ROS: really involved in oxygen sensing. , 2005, Cell metabolism.

[16]  N. Denko,et al.  HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. , 2006, Cell metabolism.

[17]  R. Altman,et al.  Investigating hypoxic tumor physiology through gene expression patterns , 2003, Oncogene.

[18]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[19]  J. Pouysségur,et al.  The Expanding Family of Eucaryotic Na+/H+Exchangers* , 2000, The Journal of Biological Chemistry.

[20]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[21]  D. Peet,et al.  Regulation of HIF: asparaginyl hydroxylation. , 2006, Novartis Foundation symposium.

[22]  Christopher J Schofield,et al.  Signalling hypoxia by HIF hydroxylases. , 2005, Biochemical and biophysical research communications.

[23]  S. Schreiber,et al.  Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Giatromanolaki,et al.  Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer , 2005, Clinical & Experimental Metastasis.

[25]  A. Harris,et al.  Hypoxia Inducible Carbonic Anhydrase IX, Marker of Tumour: Hypoxia, Survival Pathway and Therapy Target , 2004, Cell cycle.

[26]  B. Ebert,et al.  Failure to prolyl hydroxylate hypoxia‐inducible factor α phenocopies VHL inactivation in vivo , 2006 .

[27]  E. Gottlieb,et al.  Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer , 2006, Oncogene.

[28]  Christopher J. Schofield,et al.  Oxygen sensing by HIF hydroxylases , 2004, Nature Reviews Molecular Cell Biology.

[29]  J. Pouysségur,et al.  Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. , 2005, Cellular signalling.

[30]  G. Gutierrez.  A mathematical model of tissue-blood carbon dioxide exchange during hypoxia. , 2004, American journal of respiratory and critical care medicine.

[31]  J. Pouysségur,et al.  The hypoxia-inducible factor and tumor progression along the angiogenic pathway. , 2005, International review of cytology.

[32]  J R Griffiths,et al.  Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. , 2005, Human molecular genetics.

[33]  E. T. Gawlinski,et al.  Acid-mediated tumor invasion: a multidisciplinary study. , 2006, Cancer research.

[34]  Stefan Walenta,et al.  Lactate: mirror and motor of tumor malignancy. , 2004, Seminars in radiation oncology.

[35]  Amato J Giaccia,et al.  The role of p53 in hypoxia-induced apoptosis. , 2005, Biochemical and biophysical research communications.

[36]  H. Pelicano,et al.  Glycolysis inhibition for anticancer treatment , 2006, Oncogene.

[37]  J. Pouysségur,et al.  Hypoxia signalling in cancer and approaches to enforce tumour regression , 2006, Nature.

[38]  M. Flentje,et al.  Glucose requirement for hypoxic accumulation of hypoxia-inducible factor-1α (HIF-1α) , 2005 .

[39]  Sandro Santagata,et al.  A HIF1α Regulatory Loop Links Hypoxia and Mitochondrial Signals in Pheochromocytomas , 2005, PLoS genetics.

[40]  F. Di Sole,et al.  Na+/H+ exchangers: physiology and link to hypertension and organ ischemia , 2005, Current opinion in nephrology and hypertension.

[41]  David Beach,et al.  Glycolytic enzymes can modulate cellular life span. , 2005, Cancer research.

[42]  N. Amariglio,et al.  Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. , 2005, Cancer research.

[43]  H. Uramoto,et al.  Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. , 2003, Cancer treatment reviews.

[44]  G. Semenza,et al.  Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1. , 2005, Blood.

[45]  A. Halestrap,et al.  The Plasma Membrane Lactate Transporter MCT4, but Not MCT1, Is Up-regulated by Hypoxia through a HIF-1α-dependent Mechanism* , 2006, Journal of Biological Chemistry.

[46]  C. Dalgard,et al.  Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1* , 2005, Journal of Biological Chemistry.

[47]  Fatima Mechta-Grigoriou,et al.  Redox regulation of the hypoxia-inducible factor , 2006, Biological chemistry.

[48]  C. Thompson,et al.  Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.

[49]  R. Gillies,et al.  Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.